SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 13G

Under the Securities and Exchange Act of 1934

 

 

Anika Therapeutics Inc

(Name of Issuer)

Common Stock

(Title of Class of Securities)

035255108

(CUSIP Number)

December 31, 2020

(Date of Event Which Requires Filing of this Statement)

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

This Schedule is filed pursuant to Rule 13d-1(b)

The information required in the remainder of this cover page (except any items to which the form provides a cross-reference) shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act.

 

 

 


CUSIP NO. 035255108

 

  1)    

  Name of Reporting Person

  Ameriprise Financial, Inc.

 

  S.S. or I.R.S. Identification No. of Above Person

  IRS No. 13-3180631

  2)  

  Check the Appropriate Box if a Member of a Group

  (a)  ☐        (b)  ☒*

 

*  This filing describes the reporting person’s relationship with other persons, but the reporting person does not affirm the existence of a group.

  3)  

  SEC Use Only

 

  4)  

  Citizenship or Place of Organization

 

  Delaware

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING PERSON

WITH

     5)      

  Sole Voting Power

 

  0

   6)      

  Shared Voting Power

 

  1,003,580

   7)      

  Sole Dispositive Power

 

  0

   8)      

  Shared Dispositive Power

 

  1,004,108

  9)    

  Aggregate Amount Beneficially Owned by Each Reporting Person

 

  1,004,108

10)  

  Check if the Aggregate Amount in Row (9) Excludes Certain Shares

 

  Not Applicable

11)  

  Percent of Class Represented by Amount In Row (9)

 

  7.07%

12)  

  Type of Reporting Person

 

  HC


CUSIP NO. 035255108

 

  1)    

  Name of Reporting Person

  Columbia Management Investment Advisers, LLC

 

  S.S. or I.R.S. Identification No. of Above Person

  IRS No. 41-1533211

  2)  

  Check the Appropriate Box if a Member of a Group

  (a)  ☐        (b)  ☒*

 

*  This filing describes the reporting person’s relationship with other persons, but the reporting person does not affirm the existence of a group.

  3)  

  SEC Use Only

 

  4)  

  Citizenship or Place of Organization

 

  Minnesota

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING PERSON

WITH

     5)      

  Sole Voting Power

 

  0

   6)      

  Shared Voting Power

 

  1,003,580

   7)      

  Sole Dispositive Power

 

  0

   8)      

  Shared Dispositive Power

 

  1,003,590

  9)    

  Aggregate Amount Beneficially Owned by Each Reporting Person

 

  1,003,590

10)  

  Check if the Aggregate Amount in Row (9) Excludes Certain Shares

 

  Not Applicable

11)  

  Percent of Class Represented by Amount In Row (9)

 

  7.06%

12)  

  Type of Reporting Person

 

  IA


CUSIP NO. 035255108

 

  1)    

  Name of Reporting Person

  Columbia Wanger Asset Management, LLC

 

  S.S. or I.R.S. Identification No. of Above Person

  IRS No. 04-3519872

  2)  

  Check the Appropriate Box if a Member of a Group

  (a)  ☐        (b)  ☒*

 

*  This filing describes the reporting person’s relationship with other persons, but the reporting person does not affirm the existence of a group.

  3)  

  SEC Use Only

 

  4)  

  Citizenship or Place of Organization

 

  Delaware

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING PERSON

WITH

     5)      

  Sole Voting Power

 

  0

   6)      

  Shared Voting Power

 

  932,719

   7)      

  Sole Dispositive Power

 

  0

   8)      

  Shared Dispositive Power

 

  932,719

  9)    

  Aggregate Amount Beneficially Owned by Each Reporting Person

 

  932,719

10)  

  Check if the Aggregate Amount in Row (9) Excludes Certain Shares

 

  Not Applicable

11)  

  Percent of Class Represented by Amount In Row (9)

 

  6.57%

12)  

  Type of Reporting Person

 

  IA


1(a)

 

Name of Issuer:

  

Anika Therapeutics Inc

1(b)

 

Address of Issuer’s Principal

  

32 Wiggins Avenue

  Executive Offices:   

Bedford, MA 01730

2(a)

 

Name of Person Filing:

  

(a) Ameriprise Financial, Inc. (“AFI”)

    

(b) Columbia Management Investment Advisers, LLC (“CMIA”)

     (c) Columbia Wanger Asset Management, LLC (“CWAM”)

2(b)

 

Address of Principal Business Office:

  

(a) Ameriprise Financial, Inc.

    

145 Ameriprise Financial Center

    

Minneapolis, MN 55474

    

(b) 225 Franklin St.

    

Boston, MA 02110

     (c) 71 S Wacker Dr., Suite 2500
     Chicago, IL 60606

2(c)

 

Citizenship:

  

(a) Delaware

    

(b) Minnesota

    

(c) Delaware

2(d)

 

Title of Class of Securities:

  

Common Stock

2(e)

 

Cusip Number:

  

035255108

 

3

Information if statement is filed pursuant to Rules 13d-1(b) or 13d-2(b):

(a) Ameriprise Financial, Inc.

A parent holding company in accordance with Rule 13d-1(b)(1)(ii)(G). (Note: See Item 7)

(b) Columbia Management Investment Advisers, LLC

An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E).

(c) Columbia Wanger Asset Management, LLC

An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E).

 

4

Incorporated by reference to Items (5)-(9) and (11) of the cover page pertaining to each reporting person.


AFI, as the parent company of CMIA and CWAM, may be deemed to beneficially own the shares reported herein by those reporting persons. Accordingly, the shares reported herein by AFI include those shares separately reported herein by those reporting persons.

Each of AFI, CMIA and CWAM disclaims beneficial ownership of any shares reported on this Schedule.

 

5

Ownership of 5% or Less of a Class: Not Applicable

 

6

Ownership of more than 5% on Behalf of Another Person: Not Applicable

 

7

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company:

AFI: See Exhibit I

 

8

Identification and Classification of Members of the Group:

Not Applicable

 

9

Notice of Dissolution of Group:

Not Applicable

 

10

Certification:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired for the purpose of and do not have the effect of changing or influencing the control of the issuer of such securities and were not acquired in connection with or as a participant in any transaction having such purposes or effect.


Signature

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: February 12, 2021

 

Ameriprise Financial, Inc.
By:  

/s/ Paul Goucher

Name:   Paul Goucher
Title:   Senior Vice President and Assistant General Counsel
Columbia Management Investment Advisers, LLC
By:  

/s/ Paul Goucher

Name:   Paul Goucher
Title:   Senior Vice President and Assistant Secretary
Columbia Wanger Asset Management, LLC
By:  

/s/ Joseph C. LaPalm

Name:   Joseph C. LaPalm
Title:   Chief Compliance Officer
Contact Information
Mark D. Braley
Vice President

Head of Reporting and Data Management |

Global Operations and Investor Services

Telephone: (617) 747-0663


Exhibit Index

 

Exhibit I    Identification and Classification of the Subsidiary which acquired the Security Being Reported on by the Parent Holding Company.
Exhibit II    Joint Filing Agreement
Anika Therapeutics (NASDAQ:ANIK)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Anika Therapeutics Charts.
Anika Therapeutics (NASDAQ:ANIK)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Anika Therapeutics Charts.